Modulation of the infant immune responses by the first pertussis vaccine administrations

Vaccine

Volumn 25, Issue 2, 2007, Pages 391-398

  Mascart, F ^a   Hainaut, M ^b   Peltier, A ^b   Verscheure, V ^a   Levy, J ^b   Locht, C ^c,d  

^a ERASME HOSPITAL   (Belgium)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^c INSERM   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Human infants; Pertussis vaccines; Th1 Th2 cells

Indexed keywords

BETA LACTOGLOBULIN; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; GAMMA INTERFERON; HAEMOPHILUS VACCINE; HEMAGGLUTININ; HEPATITIS B VACCINE; INTERLEUKIN 12P70; PERTUSSIS TOXIN; PERTUSSIS VACCINE; PHYTOHEMAGGLUTININ; TETANUS TOXOID; TETRAVAC; ZIDOVUDINE;

ANTIGEN SPECIFICITY; ARTICLE; CYTOKINE RELEASE; DIPHTHERIA; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOMODULATION; INFANT; MAJOR CLINICAL STUDY; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; TETANUS; VACCINATION; WHOLE CELL;

ADHESINS, BACTERIAL; ANTIBODIES, BACTERIAL; HUMANS; INFANT; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-5; LACTOGLOBULINS; PERTUSSIS VACCINE; TH1 CELLS; TH2 CELLS; VACCINATION; VIRULENCE FACTORS, BORDETELLA;

EID: 33845327856     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.06.046     Document Type: Article

References (31)

1. Frenkel L., and Bryson Y.J. Ontogeny of phytohemagglutinin-induced γ interferon by leukocytes of healthy infants and children: evidence for decreased production in infants younger than 2 months of age. J Pediatr 111 (1987) 97-100
2. Prescott S.L., Macaubas C., Holt B.J., Smallacombe T.B., Loh R., Sly P.D., et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward Th2 cytokine profile. J Immunol 160 (1998) 4730-4737
3. Ribeiro-do-Couto L.M., Boeije L.C.M., Kroon J.S., Hooibrink B., Breur-Vriesendorp B.S., Aarden L.A., et al. High IL-13 production by human neonatal T cells: neonate immune system regulator?. Eur J Immunol 31 (2001) 3394-3402
4. Rowe J., Macaubas C., Monger T.M., Holt B.J., Harvey J., Poolman J.T., et al. Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized. Infect Immun 68 (2000) 3873-3877
5. Rowe J., Macaubas C., Monger T., Holt B.J., Harvey J., Poolman J.T., et al. Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic Th1 function. J Infect Dis 184 (2001) 80-88
6. Holt P.G., Clough J.B., Holt B.J., Baron-Hay M.J., Rose A.H., and Robinson B.T.W.R. Genetic "risk" for atopy is associated with delayed postnatal maturation of T-cell competence. Clin Exp Allergy 22 (1992) 1093-1099
7. Holt P.G. Key factors in the development of asthma: atopy. Am J Respir Crit Care Med 161 (2000) S172-S175
8. Van der Velden V.H.J., Laan M.P., Baert M.R.M., De Wael Malefyt R., Neijens H.J., and Savelkoul H.F.J. Selective development of a strong Th2 cytokine profile in high-risk children who develop atopy: risk factors and regulatory role of IFN-γ, IL-4 and IL-10. Clin Exp Allergy 31 (2001) 997-1006
9. Mascart F., Verscheure V., Malfroot A., Hainaut M., Piérard D., Temerman S., et al. Bordetella pertussis infection in 2-months-old infants promotes type 1 T cell responses. J Immunol 170 (2003) 1504-1509
10. Vekemans J., Amedei A., Ota M.O., D'Elios M.M., Goetghebuer T., Ismaili J., et al. Neonatal bacillus Calmette-Guérin organism induces adult-like IFN-γ production by CD4 + T lymphocytes. Eur J Immunol 31 (2001) 1531-1535
11. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347 (2002) 911-920
12. Ota M.O.C., Vekemans J., Schlegel-Haueter S.E., Fielding K., Sanneh M., Kidd M., et al. Influence of Mycobacterium bovis Bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol 168 (2002) 919-925
13. Hewlett E.L., and Edwards K.M. Pertussis-not just for kids. N Engl J Med 352 (2005) 1215-1222
14. Decker M.D., Edwards K.M., Steinhoff M.C., Rennels M.B., Pichichero M.E., Englund J.A., et al. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 96 (1995) 557-566
15. Edwards K.M., and Decker M.D. Acellular pertussis vaccines for infants. N Engl J Med 334 (1996) 391-392
16. Mills H.G.M. Immunity to Bordetella pertussis. Microbes Infect 3 (2001) 655-677
17. Ausiello C.M., Urbani F., La Sala A., Lande R., and Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccine. Infect Immun 65 (1997) 2168-2174
18. Ryan M., Murphy G., Ryan E., Nilsson L., Shackley F., Gothefors L., et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93 (1998) 1-10
19. Gruber C., Lau S., Dannemann A., Sommerfield C., Wahn U., and Aalberse R.C. Down-regulation of IgE and IgG4 antibodies to tetanus toxoid and diphtheria toxoid by covaccination with cellular Bordetella pertussis vaccine. J Immunol 167 (2001) 2411-2417
20. Poolman J., Kaufhold A., De Grave D., and Goldblatt D. Clinical relevance of lower Hib response in DTPa-based combination vaccines. Vaccine 19 (2001) 2280-2285
21. Trolfors B., Taranger J., Lagergärd T., and Sundh V. Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid. Pediat Infect Dis J 24 (2005) 85-86
22. Goriely S., Vincart B., Stordeur P., Vekemans J., Willems F., Goldman M., et al. Deficient IL-12 (p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 166 (2001) 2141-2146
23. Lavigne M.V., Castro M., Mateo N., Deluchi S., Atzori C., Piudo L., et al. Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen. Microbes Infect 4 (2002) 815-820
24. Matuhasi T., and Ikegami H. Elevation of levels of IgE antibody to tetanus toxoïd in individuals vaccinated with diphtheria-pertussis-tetanus vaccine. J Infect Dis 146 (1982) 290
25. Mark A., Björksten B., and Granström M. Immunoglobulin E responses to diphtheria and tetanus toxoïds after booster with aluminium-adsorbed and fluid DT-vaccines. Vaccine 13 (1995) 669-673
26. Edelman K., Malmström K., He Q., Savolainen J., Terho E.O., and Mertsola J. Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria-tetanus-pertussis immunization. Eur J Pediatr 158 (1999) 989-994
27. Rowe J., Yerkovich S.T., Richmond P., Suriyaarachchi D., Fisher E., Feddema L., et al. Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children. Infect Immun 73 (2005) 8130-8135
28. Rook G.A.W., Dheda K., and Zumla A. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat Rev Immunol 5 (2005) 661-667
29. Shirakawa T., Enomoto T., Shimazu S., and Hopkin J.M. Inverse association between tuberculin responses and atopic disorder. Science 275 (1997) 77-79
30. Nilsson L., Kjellman N.I., and Bjorksten B. Allergic disease at the age of 7 years after pertussis vaccination in infancy: results from the follow-up of a randomized controlled trial of 3 vaccines. Arch Pediatr Adolesc Med 157 (2003) 1184-1189
31. Holt P.G., Rowe J., Loh R., and Sly P.D. Developmental factors associated with risk for atopic disease: implications for vaccine strategies in early childhood. Vaccine 21 (2003) 3432-3435